Orrick Advises capAI on R42 Group Alliance

Orrick advised capAI plc (LSE: CPAI), an AI innovation business listed on the London Stock Exchange Main Market, regarding its Alliance with R42 Group, LLC, a venture capital firm located in Palo Alto, California. This took place on May 27, 2025.

The Alliance with R42, effective June 1, 2025, will improve capAI's operating model (Identify; Incubate; and Invent) through a transatlantic platform. This platform is for sourcing, developing, and commercializing early-stage AI opportunities within the media and medicine sectors, while also allowing for strategic flexibility in pursuing high-growth opportunities across the wider AI landscape.

The Alliance allows capAI to use R42's existing network and infrastructure to access high-quality innovation with capital efficiency, which positions capAI to pursue AI breakthrough opportunities.

Richard Edwards, Executive Chairman of capAI, said that the Alliance with R42 is a major step in executing their refined operating strategy and establishes a transatlantic innovation platform that combines AI expertise, capital efficiency, and public market access. He added that the projects under review show their commitment to AI solutions in media and medicine and align with their vision of AI-empowered value creation.

Professor Ronjon Nag, Founder of R42, stated that the Alliance creates an innovation pipeline, linking AI ventures with the resources and execution capabilities needed to scale. He added that by combining R42's venture-building expertise with capAI's public market access, they can accelerate the commercialization of breakthrough technologies, reflecting their shared commitment to capital-efficient innovation and the pursuit of AI opportunities in media and medicine.

The Orrick team was led by Ed Dyson and included Faraaz Samadi, Rebecca Servian, Michael Wiesner, Shannon Yavorsky, Abigail Parkin, Charles Sheldon, and James Labovitch.